NEW YORK - Pfizer on Wednesday shared data about a third dose of its COVID-19 vaccine that suggests it "strongly" boosts protection against the more contagious delta variant of the coronavirus, which has driven a recent surge in U.S.
cases and hospitalizations. The drugmaker released limited data from its ongoing booster trial as part of its second-quarter earnings report.